The impact of different treatment modalities and prognostic factors on the clinical course of primary thyroid diffuse large B-cell lymphoma (PTDLBCL) is still the subject of research. This study was conducted to clarify these clinical aspects of this disorder. The clinical parameters of 48 patients with PTDLBCL at time of diagnosis were comparable to those of previous studies. Patients underwent either radiotherapy (RT)  ±  surgery (SX), chemotherapy (CHT) alone or in combination with local treatments (RT or SX), or SX followed by CHT and RT. A 90% complete remission (CR) rate was observed among patients who underwent combined treatment modalities (CTM), compared to 76% among the others. The 5-year progression-free survival differed significantly between both groups (p = 0.028). Poor performance status and advanced age correlated with decreased survival. PTDLBCL is a curable disease prevalent in elderly patients. Combined treatment modalities were able to induce an elevated rate of CR, improving long-term survival in younger patients. However, the outcome in elderly patients still remains unsatisfactory.

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study / Mian, M.; Gaidano, G.; Conconi, A.; Tsang, R.; Gospodarowicz, M. K.; Rambaldi, A.; Rossi, A.; Oldani, E.; Federico, Massimo; Luminari, Stefano; Bellei, Monica; Pogliani, E. M.; Rossini, F.; Cabrera, M. E.; Martelli, M.; Lopez Guillermo, A.; Busetto, M.; Cavalli, F.; Zucca, E.; Cortelazzo, S.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - ELETTRONICO. - 52:5(2011), pp. 823-832. [10.3109/10428194.2011.555888]

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study

FEDERICO, Massimo;LUMINARI, Stefano;BELLEI, Monica;
2011

Abstract

The impact of different treatment modalities and prognostic factors on the clinical course of primary thyroid diffuse large B-cell lymphoma (PTDLBCL) is still the subject of research. This study was conducted to clarify these clinical aspects of this disorder. The clinical parameters of 48 patients with PTDLBCL at time of diagnosis were comparable to those of previous studies. Patients underwent either radiotherapy (RT)  ±  surgery (SX), chemotherapy (CHT) alone or in combination with local treatments (RT or SX), or SX followed by CHT and RT. A 90% complete remission (CR) rate was observed among patients who underwent combined treatment modalities (CTM), compared to 76% among the others. The 5-year progression-free survival differed significantly between both groups (p = 0.028). Poor performance status and advanced age correlated with decreased survival. PTDLBCL is a curable disease prevalent in elderly patients. Combined treatment modalities were able to induce an elevated rate of CR, improving long-term survival in younger patients. However, the outcome in elderly patients still remains unsatisfactory.
2011
52
5
823
832
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study / Mian, M.; Gaidano, G.; Conconi, A.; Tsang, R.; Gospodarowicz, M. K.; Rambaldi, A.; Rossi, A.; Oldani, E.; Federico, Massimo; Luminari, Stefano; Bellei, Monica; Pogliani, E. M.; Rossini, F.; Cabrera, M. E.; Martelli, M.; Lopez Guillermo, A.; Busetto, M.; Cavalli, F.; Zucca, E.; Cortelazzo, S.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - ELETTRONICO. - 52:5(2011), pp. 823-832. [10.3109/10428194.2011.555888]
Mian, M.; Gaidano, G.; Conconi, A.; Tsang, R.; Gospodarowicz, M. K.; Rambaldi, A.; Rossi, A.; Oldani, E.; Federico, Massimo; Luminari, Stefano; Bellei, Monica; Pogliani, E. M.; Rossini, F.; Cabrera, M. E.; Martelli, M.; Lopez Guillermo, A.; Busetto, M.; Cavalli, F.; Zucca, E.; Cortelazzo, S.
File in questo prodotto:
File Dimensione Formato  
10428194%2E2011%2E555888.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 909.43 kB
Formato Adobe PDF
909.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/662448
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 18
social impact